Emerald Mutual Fund Advisers Trust Oncocyte Corp Put Options Transaction History
Emerald Mutual Fund Advisers Trust
- $1.76 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OCX
# of Institutions
4Shares Held
1.5MCall Options Held
0Put Options Held
0-
Awm Investment Company, Inc. New York, NY1.1MShares$3.28 Million0.5% of portfolio
-
Act Capital Management, LLC Wayne, PA330KShares$986,7000.33% of portfolio
-
Defender Capital, Llc.55.2KShares$165,1070.06% of portfolio
-
American Portfolios Advisors Holbrook, NY21.8KShares$65,2710.0% of portfolio
About Oncocyte Corp
- Ticker OCX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,609,000
- Market Cap $355M
- Description
- OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....